Our Scientific Advisory Board
Our Scientific Advisory Board brings together leading experts to guide our mission of transforming healthcare research.
Dr. Lishomwa Ndhlovu
Leader of the Scientific Advisory Board
Lishomwa Ndhlovu is a Professor of Immunology in Medicine at Weil Cornell Medicine, NY, in the Division of Infectious Diseases. His research focuses on understanding the pathogenic mechanisms underlying complications impacting brain health and co-infections in HIV particularly among those receiving virally suppressive antiretroviral therapy across a spectrum of ages. Using multiple immunological, virological and molecular epigenetic and genetic modalities, he aims to exploit this knowledge in developing novel approaches and effective therapeutics to improving quality of life outcomes. He is actively engaged in pre-clinical and clinical studies nationally and internationally to achieve these goals.
Yngvar Fløisand
Consultant the Center for Cell Therapy and Allogeneic Stem Cell transplantation at Karolinska University Hospital and Associate Professor at the University of Bergen
Yngvar Fløisand finished medical school in Düsseldorf in 1995 and went on to specialise in Internal Medicine and Haematology. Dr Fløisand did his PhD on dendritic cells at the Dept of Immunology at Oslo University Hospital/ University of Oslo. At Oslo University Hospital, he led the program for Acute Myeloid Leukaemia. He has been involved in clinical trials, phase I-III, in acute leukemias and allogeneic stem cell transplantation as well as translational research. Furthermore, he has been deeply involved in the design, setup and running of registries in haematologic malignancies and stem cell transplants.
Ole A. Andreassen
Currently professor in psychiatry at University of Oslo, PI for the group Precision Psychiatry, and has previously headed the CoE Norwegian Centre for Mental Disease Research (NORMENT).
Andreassen did his post doc training in molecular neuroscience at Massachusetts General Hospital. He is now an attending psychiatrist at Oslo University Hospital. His research is translational and he applies clinical, neurocognitive, and brain imaging phenotypes and molecular genetics tools to identify causes and underlying pathophysiology of mental disorders, and develop multimodal stratification tools. Andreassen builds his research on the Nordic advantages, such as public health care system, large biobanks, health registries and homogenous populations, and is currently focusing on gene x environment interplay and development of precision medicine approaches in psychiatry. He is chairing international consortia in mental disorder genetics (PGC) and brain imaging (ENIGMA), and coordinates European Bipolar Disorder Network (ECNP) and Horizon2020 projects (CoMorMent).
Steven Deeks MD
Dr. Deeks is Professor of Medicine at the University of California, San Francisco (UCSF).
He is an internationally recognized expert in HIV pathogenesis and treatment. He is the Principal Investigator of the NIH-funded Martin Delaney HIV Cure Collaboratory, “DARE”, focused on developing therapeutic interventions to cure HIV infection. He also leads a large NIH funded program focused on Long COVID. He has published over 700 articles on these topics. In addition to his translational and clinical research, he maintains a primary care clinic for people living with HIV.
